IPA predicted the up- and downregulation of several immunomodulatory molecules at both timepoints (Fig. 3c), including FGF2, which is known to support ZIKV infection by suppressing IFN signaling (Limonta et al., 2019). This evidence concerns the gene FGF2 and Zika virus infectious disease.